Autobio Diagnostics Co Ltd (603658) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.049x

Based on the latest financial reports, Autobio Diagnostics Co Ltd (603658) has a cash flow conversion efficiency ratio of 0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥435.24 Million ≈ $63.69 Million USD) by net assets (CN¥8.85 Billion ≈ $1.29 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Autobio Diagnostics Co Ltd to measure how many days the company can operate on defensive assets alone.

Autobio Diagnostics Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Autobio Diagnostics Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Autobio Diagnostics Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Autobio Diagnostics Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Kitron ASA OL:KIT	0.014x
Tarsus Pharmaceuticals Inc NASDAQ:TARS	-0.071x
Kingclean Electric Co Ltd SHG:603355	0.040x
China Leadshine Technology Co Ltd SHE:002979	0.074x
FOCI Fiber Optic Communications TWO:3363	0.036x
Vivendi SA PA:VIV	-0.007x
Artisan Partners Asset Management Inc NYSE:APAM	0.354x
Customers Bancorp, Inc. NYSE:CUBI	0.016x

Annual Cash Flow Conversion Efficiency for Autobio Diagnostics Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Autobio Diagnostics Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Autobio Diagnostics Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥8.69 Billion ≈ $1.27 Billion	CN¥1.31 Billion ≈ $191.59 Million	0.151x	-11.19%
2023-12-31	CN¥8.67 Billion ≈ $1.27 Billion	CN¥1.47 Billion ≈ $215.09 Million	0.170x	-13.89%
2022-12-31	CN¥7.91 Billion ≈ $1.16 Billion	CN¥1.56 Billion ≈ $228.05 Million	0.197x	-0.21%
2021-12-31	CN¥7.40 Billion ≈ $1.08 Billion	CN¥1.46 Billion ≈ $213.82 Million	0.197x	+30.67%
2020-12-31	CN¥6.59 Billion ≈ $963.64 Million	CN¥994.71 Million ≈ $145.56 Million	0.151x	-52.79%
2019-12-31	CN¥2.63 Billion ≈ $385.52 Million	CN¥842.89 Million ≈ $123.34 Million	0.320x	-3.79%
2018-12-31	CN¥1.97 Billion ≈ $287.67 Million	CN¥653.73 Million ≈ $95.66 Million	0.333x	+16.62%
2017-12-31	CN¥1.69 Billion ≈ $247.22 Million	CN¥481.73 Million ≈ $70.49 Million	0.285x	+12.80%
2016-12-31	CN¥1.64 Billion ≈ $240.70 Million	CN¥415.82 Million ≈ $60.85 Million	0.253x	-41.15%
2015-12-31	CN¥718.55 Million ≈ $105.15 Million	CN¥308.63 Million ≈ $45.16 Million	0.430x	-16.26%
2014-12-31	CN¥500.94 Million ≈ $73.30 Million	CN¥256.93 Million ≈ $37.60 Million	0.513x	+69.15%
2013-12-31	CN¥340.42 Million ≈ $49.81 Million	CN¥103.22 Million ≈ $15.10 Million	0.303x	+2.28%
2012-12-31	CN¥233.84 Million ≈ $34.22 Million	CN¥69.32 Million ≈ $10.14 Million	0.296x	-8.02%
2011-12-31	CN¥156.96 Million ≈ $22.97 Million	CN¥50.59 Million ≈ $7.40 Million	0.322x	--

About Autobio Diagnostics Co Ltd

SHG:603658 China Medical Devices

Market Cap

$2.55 Billion

CN¥17.42 Billion CNY

Market Cap Rank

#5537 Global

#1095 in China

Share Price

CN¥30.49

Change (1 day)

-1.74%

52-Week Range

CN¥29.71 - CN¥42.46

All Time High

CN¥131.73